Skip to main content

Bayer is growing in Basel

| News

Bayer is growing in Basel


The German life sciences company Bayer wants to continue to grow in Basel, as company representatives announced in a press conference. Bayer settled in Basel in 2005. Since then, the number of employees has risen from 120 to 750. For the coming years, the group expects 100 additional employees per year. The workforce includes people from 60 nations.

Bayer. (Img: Bayer AG)

Of the 750 employees, 500 work in the Consumer Health sector, which includes non-prescription drugs such as aspirin, bepanthen or Alka-Seltzer. Since 2016, Basel is the global headquarter of this division. In addition, parts of Bayer’s pharmaceutical division are also operating from Basel. These include employees in the fields of oncology, ophthalmology and hematology. These departments recorded the largest increase in new employees.

According to Bayer, the company can chose from 7,000 applications per year. The Group benefits from the Basel Life Sciences Cluster as well as its proximity to pharmaceutical giants like Roche and Novartis.

As the company’s representatives stated, Basel’s location is not more expensive than others, but more attractive. And since employees in Basel could gain extensive experience within a short time, the location works like a talent hub for the entire group. In order to adjust to the growth, the company invested 20 million Swiss francs in the reconstruction of its office space in the Peter Merian building in Basel.

Bayer is also located in the Infrapark Baselland with an offshoot of its agrochemical division. Bepanthen is produced in Grenzach-Wyhlen. With more locations in Zurich and Zollikofen, Bayer employs more than 1200 people in Switzerland, 115’200 worldwide. In 2016, the company had a turnover of 46.8 Euro billion.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

biGENIUS receives 2 million euros for new cloud product

Software company biGENIUS, based in the Basel Area, has secured financing of 2 million euros. This funding was granted following...
Read More

Opterion Health secures investment of 6.5 million Swiss francs

Opterion Health has raised a total of 6.5 million Swiss francs as part of a financing round. The company, which...
Read More

TOLREMO receives 39 million US dollars in investments

TOLREMO Therapeutics has concluded a series A funding round with 39 million US dollars. The biotech company based in Basel...
Read More

Mazars opens tenth Swiss office in Basel

Mazars is now also present in Basel with a subsidiary as of September 1. This is the tenth Swiss location...
Read More

Medtech in Switzerland – bringing together traditional skills and hightech industry

How the intersection of traditional and novel skillsets in the Jura area is propelling Switzerland into a new era of...
Read More

Fondation Botnar supporting further research into pediatric health

The Basel-based Botnar Research Centre for Child Health has received a further donation of 50 million Swiss francs from the...
Read More

Do you have a question? We'd like to hear from you.